• Featured Product
  • KD/KO Validated

CIP2A Polyclonal antibody

CIP2A Polyclonal Antibody for WB, IHC, ELISA

Host / Isotype

Rabbit / IgG

Reactivity

human

Applications

WB, IHC, IF, ELISA

Conjugate

Unconjugated

Cat no : 23199-1-AP

Synonyms

Cancerous inhibitor of PP2A, CIP2A, KIAA1524, p90, p90 autoantigen, Protein CIP2A



Tested Applications

Positive WB detected inA549 cells, HEK-293 cells, U2OS cells
Positive IHC detected inhuman lung cancer tissue, human breast cancer tissue
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0

Recommended dilution

ApplicationDilution
Western Blot (WB)WB : 1:500-1:2000
Immunohistochemistry (IHC)IHC : 1:50-1:500
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

The immunogen of 23199-1-AP is CIP2A Fusion Protein expressed in E. coli.

Tested Reactivity human
Cited Reactivityhuman
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen CIP2A fusion protein Ag19598
Full Name KIAA1524
Calculated Molecular Weight 905 aa, 102 kDa
Observed Molecular Weight 80-102 kDa
GenBank Accession NumberBC130564
Gene Symbol CIP2A
Gene ID (NCBI) 57650
RRIDAB_2918079
Conjugate Unconjugated
Form Liquid
Purification MethodAntigen Affinity purified
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Background Information

Cancerous inhibitor of protein phosphatase 2A (CIP2A) was originally identified as a cellular protein phosphatase 2A (PP2A) inhibitor, and has been shown to control oncogenic cellular signals by suppressing the tumor suppressor PP2A. CIP2A overexpression has been found in several human malignancies including breast cancer, hepatocellular carcinoma, gastric cancer, head and neck cancer, colon cancer, prostate cancer and non-small cell lung cancer. CIP2A is a 83~102 kDa cytoplasmic protein. ( PMID: 26824320, PMID: 25458953, PMID: 29720672)

Protocols

Product Specific Protocols
WB protocol for CIP2A antibody 23199-1-APDownload protocol
IHC protocol for CIP2A antibody 23199-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

SpeciesApplicationTitle
WB,IF

Biochim Biophys Acta Mol Basis Dis

Loss of function variant in CIP2A associated with female infertility with early embryonic arrest and fragmentation

Authors - Zhenxing Liu
humanWB

Smart Med

TP53 mutation-related senescence is an indicator of hepatocellular carcinoma patient outcomes from multiomics profiles

Authors - Yu-Yan Chen